Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Newsletter The Access Campaign Newsletters Read, watch, share Filter by - Any -BlogCampaignEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefThe issuesTopic overviewVideo Newsletter Newsletter | 05 May 2022 COVID-19 Reject the FLAWED COVID proposal at WTO for equitable access to medical tools Newsletter Newsletter | 28 April 2022 COVID-19 Share vaccine tech! Prepare for the future! Newsletter Newsletter | 01 January 2022 Diabetes HIV/AIDS Tropical & neglected diseases Vaccines Our Wishlist for 2022 Newsletter Newsletter | 03 November 2021 COVID-19 No profit in a pandemic! Moderna must share COVID-19 vaccine technology now Newsletter Newsletter | 11 October 2021 COVID-19 Break the TRIPS Waiver deadlock! Newsletter Newsletter | 07 October 2021 COVID-19 Redistribute excess COVID-19 vaccines to people who need them most Newsletter Newsletter | 02 October 2021 COVID-19 The Waiver campaign is one year old. It’s not a time to celebrate but a time to act. Newsletter Newsletter | 10 September 2021 COVID-19 Share the Tech – Save Lives Load More
Newsletter Newsletter | 05 May 2022 COVID-19 Reject the FLAWED COVID proposal at WTO for equitable access to medical tools
Newsletter Newsletter | 01 January 2022 Diabetes HIV/AIDS Tropical & neglected diseases Vaccines Our Wishlist for 2022
Newsletter Newsletter | 03 November 2021 COVID-19 No profit in a pandemic! Moderna must share COVID-19 vaccine technology now
Newsletter Newsletter | 07 October 2021 COVID-19 Redistribute excess COVID-19 vaccines to people who need them most
Newsletter Newsletter | 02 October 2021 COVID-19 The Waiver campaign is one year old. It’s not a time to celebrate but a time to act.